Management of Neonatal Abstinence Syndrome from Opioids

Artigo de acesso restrito

GRIM, Kendra et al. Management of Neonatal Abstinence Syndrome from Opioids Clinics in Perinatology, Volume 40, Issue 3, 509 – 524

Most infants at risk for neonatal abstinence syndrome have opioid plus another drug exposure; polypharmacy is the rule rather than the exception. Scales for evaluation of neonatal abstinence syndrome are primarily based for opioid withdrawal. A standard protocol to treat neonatal abstinence syndrome has not been developed. Institute nonpharmacologic strategies for all neonates at risk. The American Academy of Pediatrics recommends mechanism-directed therapy (treat opioid withdrawal with an opioid) as the first-line therapy. Second-line medications are currently under evaluation.

Keywords: Opioids, Neonatal, Abstinence, Withdrawal, Methadone, Buprenorphine

Disponível em:
< http://www.perinatology.theclinics.com/article/S0095-5108(13)00059-6/abstract >